secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001425450-26-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q1 revenue up 13% to $59.4M; lifts FY2026 guidance to $263-267M
-------------------------------------------------------------------------------

- Revenue $59.4M (13% YoY); US +11%, International +22%; Trauma & Deformity +14%, Scoliosis +13%.
- Adjusted EBITDA of $2.2M vs. -$0.4M in Q1 2025; net loss unchanged at $10.7M (-$0.45 EPS).
- Free cash flow usage improved 40% to -$5.0M from -$8.4M.
- FY2026 revenue guidance raised to $263-267M (prior $262-266M); adj. EBITDA reiterated ~$25M.
- Cash & equivalents $50.9M (down from $62.9M at Dec 31, 2025).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000032/0001425450-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000032/kids-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001425450-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer